Date published: 2025-9-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

FACL6 Inhibitors

FACL6 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of FACL6, also known as fatty acyl-CoA ligase 6. FACL6 is an enzyme that plays a key role in lipid metabolism by catalyzing the activation of long-chain fatty acids through the formation of fatty acyl-CoA thioesters. This process is essential for various downstream metabolic pathways, including β-oxidation of fatty acids, lipid synthesis, and the regulation of intracellular lipid storage. By inhibiting FACL6, researchers can explore the mechanisms of fatty acid activation and its role in cellular energy balance, lipid homeostasis, and the regulation of metabolic flux.

The mechanism of FACL6 inhibitors typically involves blocking the enzyme's ability to bind long-chain fatty acids or interfering with its active site where ATP and CoA are utilized to form the fatty acyl-CoA intermediate. Structurally, these inhibitors are often designed to mimic the natural substrates of FACL6 or the transition states of the reaction, enabling them to bind with high specificity and affinity to the enzyme. The use of FACL6 inhibitors is crucial for studying how fatty acid metabolism is regulated in different tissues and how disruptions in this process affect cellular functions. By modulating FACL6 activity, researchers gain insights into the dynamics of lipid utilization, storage, and the broader implications of fatty acid metabolism in maintaining cellular energy homeostasis and lipid signaling pathways. These inhibitors are valuable tools for understanding the intricate network of metabolic processes that are central to energy production and lipid regulation.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol could lead to the downregulation of FACL6 by activating sirtuins, which may result in the deacetylation of transcription factors and a subsequent decrease in the expression of specific genes including those in lipid metabolism.

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Metformin may decrease FACL6 expression through the activation of AMP-activated protein kinase (AMPK), which can inhibit biosynthetic processes, including fatty acid synthesis, to conserve cellular energy levels.